Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Subpotent Drug Recalled
03/07/2024
Bausch Health Companies Inc. is recalling 3600 cartons of omeprazole and sodium bicarbonate powder for oral suspension distributed by Oceanside Pharmaceuticals.
Bausch Health Companies Inc. is recalling 3600 cartons of omeprazole and sodium bicarbonate powder for oral suspension distributed by Oceanside Pharmaceuticals.
Bausch Health Companies Inc. is...
03/07/2024
Pharmacy Learning Network
News
Ulcerative Colitis Drug Recalled
03/07/2024
Sun Pharmaceuticals is recalling mesalamine extended-release capsules after samples failed to meet dissolution specifications during routine testing.
Sun Pharmaceuticals is recalling mesalamine extended-release capsules after samples failed to meet dissolution specifications during routine testing.
Sun Pharmaceuticals is recalling...
03/07/2024
Pharmacy Learning Network
News
OTC Eye Ointments Recalled for Sterility Concerns
03/06/2024
The ointments were distributed by Walmart, CVS, and AACE Pharmaceuticals.
The ointments were distributed by Walmart, CVS, and AACE Pharmaceuticals.
The ointments were distributed...
03/06/2024
Pharmacy Learning Network

Advertisement

News
Moderna Anticipates Approval Decision for RSV Vaccine in May
03/05/2024
Moderna’s experimental respiratory syncytial virus (RSV) vaccine is garnering high expectations from investors, according to a recent Biopharma Dive article.
Moderna’s experimental respiratory syncytial virus (RSV) vaccine is garnering high expectations from investors, according to a recent Biopharma Dive article.
Moderna’s experimental...
03/05/2024
Pharmacy Learning Network
News
Global GLP-1 Agonist Market Trends
03/04/2024

Emry Lloyd

Emry Lloyd
The 2024 Market Research Report was released, and new information was discussed on the global glucagon-like peptide 1 (GLP-1) agonist market. The GLP-1 market has shown a steady increase of 20.6% CAGR between 2020 and 2023.
The 2024 Market Research Report was released, and new information was discussed on the global glucagon-like peptide 1 (GLP-1) agonist market. The GLP-1 market has shown a steady increase of 20.6% CAGR between 2020 and 2023.
The 2024 Market Research Report...
03/04/2024
Pharmacy Learning Network
News
Will Popular Weight Loss Drugs Increase Eating Disorders?
03/01/2024
Some experts are concerned the popularity of the glucagon-like peptide-1 receptor (GLP-1) agonist semaglutide for weight loss could trigger a rise in eating disorders, CNN recently reported.
Some experts are concerned the popularity of the glucagon-like peptide-1 receptor (GLP-1) agonist semaglutide for weight loss could trigger a rise in eating disorders, CNN recently reported.
Some experts are concerned the...
03/01/2024
Pharmacy Learning Network

Advertisement

News
Injection Recalled for Incorrect Label
02/29/2024
An incorrect expiration date on the product label has prompted the recall of 1099 vials of Adrenalin (epinephrine) injection packaged by Henry Schein Inc., according to the February 28, 2024, US Food and Drug Administration (FDA) Enforcement...
An incorrect expiration date on the product label has prompted the recall of 1099 vials of Adrenalin (epinephrine) injection packaged by Henry Schein Inc., according to the February 28, 2024, US Food and Drug Administration (FDA) Enforcement...
An incorrect expiration date on...
02/29/2024
Pharmacy Learning Network
News
UTI Antibiotic Recalled
02/29/2024
More than 70,000 single-dose sachets of fosfomycin tromethamine granules for oral solution distributed by Ascend Laboratories are recalled after samples of the product tested out-of-specification for organic impurities.
More than 70,000 single-dose sachets of fosfomycin tromethamine granules for oral solution distributed by Ascend Laboratories are recalled after samples of the product tested out-of-specification for organic impurities.
More than 70,000 single-dose...
02/29/2024
Pharmacy Learning Network
News
Class I Recall for Elixirs, Tablets Featuring Unapproved Drug
02/29/2024
A Class I recall has been issued for all Neptune’s Fix products because they contain tianeptine, an ingredient that is not approved for any medical use in the United States.
A Class I recall has been issued for all Neptune’s Fix products because they contain tianeptine, an ingredient that is not approved for any medical use in the United States.
A Class I recall has been issued...
02/29/2024
Pharmacy Learning Network

Advertisement

News
Weight-Loss Product Use Increases Globally Among Female Adolescents
02/26/2024
Adolescent girls frequently use weight-loss products, highlighting the need for interventions to reduce their usage, according to a study published in JAMA Network Open.
Adolescent girls frequently use weight-loss products, highlighting the need for interventions to reduce their usage, according to a study published in JAMA Network Open.
Adolescent girls frequently use...
02/26/2024
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use